SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022832
Filing Date
2022-08-15
Accepted
2022-08-15 15:46:57
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1762296
2 ex10-7.htm EX-10.7 8427
3 ex31-1.htm EX-31.1 19047
4 ex32-1.htm EX-32.1 8520
5 ex10-7_001.jpg GRAPHIC 364732
6 ex10-7_002.jpg GRAPHIC 425886
7 ex10-7_003.jpg GRAPHIC 468343
8 ex10-7_004.jpg GRAPHIC 447551
9 ex10-7_005.jpg GRAPHIC 329831
10 ex10-7_006.jpg GRAPHIC 242712
11 ex10-7_007.jpg GRAPHIC 91865
12 ex10-7_008.jpg GRAPHIC 75778
  Complete submission text file 0001493152-22-022832.txt   12057729

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE atrx-20220630.xsd EX-101.SCH 50006
14 XBRL CALCULATION FILE atrx-20220630_cal.xml EX-101.CAL 37014
15 XBRL DEFINITION FILE atrx-20220630_def.xml EX-101.DEF 243987
16 XBRL LABEL FILE atrx-20220630_lab.xml EX-101.LAB 402054
17 XBRL PRESENTATION FILE atrx-20220630_pre.xml EX-101.PRE 310512
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1357908
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 221165392
SIC: 2834 Pharmaceutical Preparations